Aptose Biosciences Inc. (APTOF) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2016: $7.33M2017: $10.20M2018: $14.08M2019: $93.93M2020: $118.92M2021: $74.24M2022: $37.74M2023: -$2.90M2024: -$4.54M2025: -$27.17M-$27.17M
2016Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$27.17M-498.0%
2024-$4.54M-56.6%
2023-$2.90M-107.7%
2022$37.74M-49.2%
2021$74.24M-37.6%
2020$118.92M+26.6%
2019$93.93M+567.0%
2018$14.08M+38.0%
2017$10.20M+39.2%
2016$7.33M